Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 443

1.

Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes.

Allen-Ramey FC, Gupta S, DiBonaventura MD.

Int J Chron Obstruct Pulmon Dis. 2012;7:779-87. doi: 10.2147/COPD.S35501.

2.

The burden of chronic obstructive pulmonary disease among employed adults.

DiBonaventura Md, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, Shah H.

Int J Chron Obstruct Pulmon Dis. 2012;7:211-9. doi: 10.2147/COPD.S29280.

3.

Burden of smoking among adults with COPD, chronic bronchitis, and emphysema in urban China.

Goren A, Gupta S, Dong P, Feng Y, Chen C, Liu D.

Int J Clin Pract. 2015 Sep;69(9):1015-28. doi: 10.1111/ijcp.12680.

PMID:
26136208
4.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA.

Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997.

5.

The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce.

DiBonaventura Md, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, Shah H.

COPD. 2012 Feb;9(1):46-57. doi: 10.3109/15412555.2011.634863.

PMID:
22292597
6.

Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.

Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X.

Int J Chron Obstruct Pulmon Dis. 2013;8:641-52. doi: 10.2147/COPD.S51245.

7.

Burden of smoking on quality of life in patients with chronic obstructive pulmonary disease.

Galaznik A, Chapnick J, Vietri J, Tripathi S, Zou KH, Makinson G.

Expert Rev Pharmacoecon Outcomes Res. 2013 Dec;13(6):853-60. doi: 10.1586/14737167.2013.842128.

PMID:
24219055
8.

Chronic obstructive pulmonary disease and associated health-care resource use - North Carolina, 2007 and 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Mar 2;61(8):143-6.

9.

Determinants of spirometry use and accuracy of COPD diagnosis in primary care.

Joo MJ, Au DH, Fitzgibbon ML, McKell J, Lee TA.

J Gen Intern Med. 2011 Nov;26(11):1272-7. doi: 10.1007/s11606-011-1770-1.

10.

Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany.

Glaab T, Vogelmeier C, Hellmann A, Buhl R.

Int J Chron Obstruct Pulmon Dis. 2012;7:101-8. doi: 10.2147/COPD.S27887.

11.

Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).

Izquierdo-Alonso JL, Rodriguez-Gonzálezmoro JM, de Lucas-Ramos P, Unzueta I, Ribera X, Antón E, Martín A.

Respir Med. 2013 May;107(5):724-31. doi: 10.1016/j.rmed.2013.01.001.

12.

Determinants and predictors of the cost of COPD in primary care: a Spanish perspective.

de Miguel Diez J, Carrasco Garrido P, García Carballo M, Gil de Miguel A, Rejas Gutierrez J, Bellón Cano JM, Hernández Barrera V, Jimenez García R.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):701-12.

13.

Changes in COPD demographics and costs over 20 years.

Blanchette CM, Dalal AA, Mapel D.

J Med Econ. 2012;15(6):1176-82. doi: 10.3111/13696998.2012.713880.

PMID:
22812689
14.

The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.

Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Sandström T, Janson C.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 28;10:2327-34. doi: 10.2147/COPD.S91362.

15.

Aspects of healthcare utilisation in self-reported obstructive lung disease.

Nielsen R, Johannessen A, Bakke PS, Askildsen JE, Omenaas ER, Gulsvik A.

Clin Respir J. 2009 Jan;3(1):34-41. doi: 10.1111/j.1752-699X.2008.00106.x.

PMID:
20298370
16.

The burden of COPD in France: results from the Confronting COPD survey.

Piperno D, Huchon G, Pribil C, Boucot I, Similowski T.

Respir Med. 2003 Mar;97 Suppl C:S33-42.

PMID:
12647941
17.

[The prevalence of COPD in Austria--the expected change over the next decade].

Firlei N, Lamprecht B, Schirnhofer L, Kaiser B, Studnicka M.

Wien Klin Wochenschr. 2007;119(17-18):513-8. German.

PMID:
17943402
18.

Economic burden of chronic bronchitis in the United States: a retrospective case-control study.

Blanchette CM, Roberts MH, Petersen H, Dalal AA, Mapel DW.

Int J Chron Obstruct Pulmon Dis. 2011 Jan 13;6:73-81. doi: 10.2147/COPD.S15882.

19.

The impact of rheumatoid arthritis on the burden of disease in urban China.

Langley PC, Mu R, Wu M, Dong P, Tang B.

J Med Econ. 2011;14(6):709-19. doi: 10.3111/13696998.2011.611201.

PMID:
21899486
20.

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC.

MMWR Surveill Summ. 2002 Aug 2;51(6):1-16.

Supplemental Content

Support Center